Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
01 1Cayman Pharma s.r.o.
02 1Chirogate International Inc
03 1EUROAPI Hungary Ltd.
04 1AX Pharmaceutical Corp
05 1Aspen Biopharma Labs Pvt Ltd
06 1Biocon Limited
07 1C-SQUARED PHARMA LIMITED
08 1DARMERICA, LLC
09 1Everlight Chemical Industrial Corporation Kuanyin II Plant
10 1FDC Limited
11 2Industriale Chimica s.r.l.
12 1Kyowa Pharma Chemical Co., Ltd.
13 1LAURUS LABS LIMITED
14 1LETCO MEDICAL, LLC
15 1MSN Laboratories Private Limited
16 1Maprimed S.A.
17 1Medisca Inc.
18 1NEWCHEM SPA
19 1Piramal Healthcare (Canada) Limited
20 1Qingdao Biopeptek Co., Ltd.
21 1SciAnda(Changshu) Pharmaceuticals, Ltd.
22 1ScinoPharm Taiwan Ltd.
23 1YS Life Science Co., Ltd.
24 1Zhejiang Ausun Pharmaceutical Co., Ltd.
01 2BIMATOPROST
02 22Bimatoprost
03 1Bimatoprost A Form
01 1Argentina
02 1Canada
03 1China
04 1Czech Republic
05 1France
06 6India
07 1Ireland
08 3Italy
09 1Japan
10 1South Korea
11 4Taiwan
12 4U.S.A
Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
NDC Package Code : 61556-070
Start Marketing Date : 2015-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Chirogate is a professional Prostaglandin manufacturer.
NDC Package Code : 68245-0004
Start Marketing Date : 2007-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
NDC Package Code : 82231-102
Start Marketing Date : 2018-03-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12079-1067
Start Marketing Date : 2010-11-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42385-030
Start Marketing Date : 2012-03-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-3066
Start Marketing Date : 2017-10-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0009
Start Marketing Date : 2001-03-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 24002-0021
Start Marketing Date : 2010-09-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54245-7036
Start Marketing Date : 2017-01-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 40016-005
Start Marketing Date : 2010-04-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Bimatoprost manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bimatoprost, including repackagers and relabelers. The FDA regulates Bimatoprost manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bimatoprost API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bimatoprost manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bimatoprost supplier is an individual or a company that provides Bimatoprost active pharmaceutical ingredient (API) or Bimatoprost finished formulations upon request. The Bimatoprost suppliers may include Bimatoprost API manufacturers, exporters, distributors and traders.
click here to find a list of Bimatoprost suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bimatoprost as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bimatoprost API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bimatoprost as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bimatoprost and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bimatoprost NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bimatoprost suppliers with NDC on PharmaCompass.
We have 23 companies offering Bimatoprost
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
